Xiaoyang Ren - Concepedia

Author

Xiaoyang Ren

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

Ren, Xiaoyang, X.-D. Ren, X.D. Ren, Xiaoyang Ren

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center First Affiliated Hospital of Xi'an Jiaotong University First Affiliated Hospital of Zhengzhou University Rice University Baylor College of Medicine

About

Xiaoyang Ren is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cell biology, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1K
2	Engineering	5	5	383
3	Natural Sciences	2	2	105
4	Health Sciences	1	1	21
5	Biochemistry	1	1	45

Xiaoyang Ren

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
A JNK-Dependent Pathway Is Required for TNFα-Induced Apoptosis Yibin Deng, Xiaoyang Ren, Lin Yang, Cell Tnfα-induced ApoptosisSignal TransductionSignaling PathwayMedicineApoptosis	2003	557
High-strength hydrogels: Fabrication, reinforcement mechanisms, and applications Heyuan Huang, Zhicheng Dong, Xiaoyang Ren, Nano Research	2023	195
On-demand intracellular amplification of chemoradiation with cancer-specific plasmonic nanobubbles Ekaterina Y. Lukianova‐Hleb, Xiaoyang Ren, Rupa R. Sawant, Nature Medicine NanomedicineEngineeringOn-demand Intracellular AmplificationTumor TargetingBiomedical Engineering	2014	170
RETRACTED: Cancer-Associated Fibroblasts-Derived Exosomes Suppress Immune Cell Function in Breast Cancer via the miR-92/PD-L1 Pathway Dongwei Dou, Xiaoyang Ren, Mingli Han, Frontiers in Immunology	2020	170
Chemoprevention of colorectal cancer by targeting APC-deficient cells for apoptosis Ling Zhang, Xiaoyang Ren, Eckhard Alt, Nature MedicineApoptosisColorectal CancerPathologyCell Death	2010	140
IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC Sonia Patel, Monique B. Nilsson, Yan Yang, Clinical Cancer Research	2023	124
Plasmonic Nanobubbles Enhance Efficacy and Selectivity of Chemotherapy Against Drug‐Resistant Cancer Cells Ekaterina Y. Lukianova‐Hleb, Xiaoyang Ren, Joseph A. Zasadzinski, Advanced Materials NanoparticlesNanotherapeuticsEngineeringBiomedical EngineeringNanomedicine	2012	116
CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis Dongwei Dou, Xiaoyang Ren, Mingli Han, Cancer Cell International	2020	102
CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance Monique B. Nilsson, Yan Yang, Simon Heeke, Cancer Cell Radiation OncologySignaling PathwayReceptor Tyrosine KinaseImmunologyImmunotherapy	2023	90
Circ_0008039 supports breast cancer cell proliferation, migration, invasion, and glycolysis by regulating the miR‐140‐3p/SKA2 axis Dongwei Dou, Xiaoyang Ren, Mingli Han, Molecular Oncology Cancer BiologyTumor BiologyMir‐140‐3p/ska2 AxisCancer Cell BiologyRadiation Oncology	2020	60

Page 1